27 January 2026 -- Solna, Sweden -- Epigenica AB announces the launch of its EpiFinder Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible.

26 January 2026 -- Stockholm, Sweden -- Recipharm, a leading global contract development and manufacturing organisation (CDMO), has developed a new, dedicated manufacturing facility to meet the latest regulatory expectations for non-bacterial beta-lactam medicines.

22 January 2026 -- New York, US -- In an effort to advance health equity and reach the people that need help most, global digital health innovator Qure.ai has received a grant from the Gates Foundation.

20 January 2026 -- Titisee-Neustadt, Germany -- Testo Saveris, global leader in measurement solutions, has announced the latest software update for its testo Saveris 1 Environmental Monitoring System, designed to address the evolving needs of the pharmaceutical industry by delivering reliable and precise monitoring of key metrics, including temperature and humidity

15 January 2026 -- Ontario, Canada -- Nicoya Life Sciences, Inc., a leading provider of advanced biophysical characterization tools for biologics discovery and development, today announced the launch of Revo, a label-free binding kinetics platform designed to make gold-standard surface plasmon resonance (SPR) data more accessible to a broader range of researchers.

13 January 2026 -- Edinburgh, UK -- Ingenza – a world-leading leading engineering biology CRDMO based in Edinburgh, Scotland – has developed GenXpress Bacillus, a powerful orthogonal protein production system.

13 January 2026 -- Maryland, US -- Sapio Sciences, the science-awareTM AI lab informatics platform, today announced the availability of trusted, third-party scientific applications and platforms now integrated directly into Sapio ELaiN, its third-generation AI lab notebook. These integrations bring well-established scientific solutions, widely used across biopharma research and development, directly into the ELaiN environment.

13 January 2026 -- New York, US -- An independently managed investment subsidiary of Investindustrial Growth III SCSp has acquired Proveris Scientific Corporation, a leader in the design and manufacture of spray and aerosol testing instrumentation, software and laboratory solutions for the pharmaceutical industry with a specialization on orally inhaled and nasal drug products.

12 January 2026 -- London, UK and Massachusetts, US -- Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use.

12 January 2026 -- California, US -- Avenue Biosciences, a protein engineering technology company, today announced $5.7M in seed extension funding round co-led by Balnord, and Tesi, with support from existing investors Voima Ventures, Inventure, University of Helsinki, and Dimerent, to scale a high-throughput protein engineering technology that accelerates the discovery of protein-based therapies and tools for the biotechnology industry.

8 January 2026 -- Massachusetts, US -- Elemental Machines, a pioneer in life sciences operational intelligence, today announced the next evolution of its operations with the expanded launch of its Agentic AI Platform. This release transforms how laboratories and manufacturing facilities turn equipment, facility, and environmental data into strategic decisions to improve operational efficiency.

2 January 2026 -- California, US -- Biotium, a leading innovator in fluorescent dyes and life science reagents, announces the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.